130 related articles for article (PubMed ID: 18007096)
1. [H.pylori in patients with cirrhosis and liver cirrhosis with hepatocellular carcinoma].
Xu MH; Qu Q; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):917-20. PubMed ID: 18007096
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma.
Leone N; Pellicano R; Brunello F; Cutufia MA; Berrutti M; Fagoonee S; Rizzetto M; Ponzetto A
Cancer Detect Prev; 2003; 27(6):494-7. PubMed ID: 14642558
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?
Ponzetto A; Pellicano R; Leone N; Cutufia MA; Turrini F; Grigioni WF; D'Errico A; Mortimer P; Rizzetto M; Silengo L
Med Hypotheses; 2000 Feb; 54(2):275-7. PubMed ID: 10790764
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated?
Wu XZ; Chen D
J Gastroenterol Hepatol; 2006 Feb; 21(2):345-7. PubMed ID: 16509857
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
6. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of HBV, HCV and HDV serum markers in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC)].
Zeng WZ; Chu RJ; Jiang MD
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):167-9. PubMed ID: 8222980
[TBL] [Abstract][Full Text] [Related]
8. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma.
Rocha M; Avenaud P; Ménard A; Le Bail B; Balabaud C; Bioulac-Sage P; de Magalhães Queiroz DM; Mégraud F
Gut; 2005 Mar; 54(3):396-401. PubMed ID: 15710989
[TBL] [Abstract][Full Text] [Related]
9. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
[TBL] [Abstract][Full Text] [Related]
10. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.
Pellicano R; Mazzaferro V; Grigioni WF; Cutufia MA; Fagoonee S; Silengo L; Rizzetto M; Ponzetto A
World J Gastroenterol; 2004 Feb; 10(4):598-601. PubMed ID: 14966925
[TBL] [Abstract][Full Text] [Related]
13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
16. [Study on Helicobacter infection in liver tissue from hepatocellular carcinoma].
Li N; Zhang SH; Xuan SY; Qiang X
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):894-6. PubMed ID: 17343186
[TBL] [Abstract][Full Text] [Related]
17. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
